Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-Drug Interaction Between Levodropropizine and Pelargonium Sidoides
NCT07017335Phase 1Completed
- Sponsor
- Pharmbio Korea Inc.
- Start
- Jun 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levodropropizine and pelargonium sidoides extract in acute bronchitis and cough (2 arms), sponsored by Pharmbio Korea Inc. Primary endpoints: Peak Plasma Concentration, Area Under the Plasma Concentration-Time Curve From Time Zero to Last Measurable Concentration and 1 more. Started Jun 2025; status: completed.
02
Drugs
levodropropizinepelargonium sidoides extract
03
Conditions
acute bronchitiscough
Beyond the preview
Go deeper on NCT07017335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07017335.